Disease-modifying treatments for multiple sclerosis - a review of approved medications von Torkildsen, Ø., Myhr, K.-M., Bø, L.

Volltext

Increasing age of multiple sclerosis onset from 1920 to 2022: a population-based study von Habbestad, A., Willumsen, J. S., Aarseth, J. H., Grytten, N., Midgard, R., Wergeland, S., Myhr, K. M., Torkildsen, Ø.

Volltext

Response to ‘Seasonal variation of vitamin D and Epstein–Barr virus antibody in multiple sclerosis patients’, a comment letter regarding ‘Vitamin D, HLA‐DRB1 and Epstein–Barr virus... von Wergeland, S., Riise, T., Torkildsen, Ø.

Volltext

The cuprizone model for demyelination von Torkildsen, O, Brunborg, L A, Myhr, K-M, Bø, L

Volltext

Vitamin D, HLA-DRB1 and Epstein-Barr virus antibody levels in a prospective cohort of multiple sclerosis patients von Wergeland, S., Myhr, K.-M., Løken-Amsrud, K. I., Beiske, A. G., Bjerve, K. S., Hovdal, H., Midgard, R., Kvistad, S. S., Holmøy, T., Riise, T., Torkildsen, Ø.

Volltext

Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study von Kuhle, J, Disanto, G, Dobson, R, Adiutori, R, Bianchi, L, Topping, J, Bestwick, JP, Meier, U-C, Marta, M, Costa, G Dalla, Runia, T, Evdoshenko, E, Lazareva, N, Thouvenot, E, Iaffaldano, P, Direnzo, V, Khademi, M, Piehl, F, Comabella, M, Sombekke, M, Killestein, J, Hegen, H, Rauch, S, D’Alfonso, S, Alvarez-Cermeño, JC, Kleinová, P, Horáková, D, Roesler, R, Lauda, F, Llufriu, S, Avsar, T, Uygunoglu, U, Altintas, A, Saip, S, Menge, T, Rajda, C, Bergamaschi, R, Moll, N, Khalil, M, Marignier, R, Dujmovic, I, Larsson, H, Malmestrom, C, Scarpini, E, Fenoglio, C, Wergeland, S, Laroni, A, Annibali, V, Romano, S, Martínez, AD, Carra, A, Salvetti, M, Uccelli, A, Torkildsen, Ø, Myhr, KM, Galimberti, D, Rejdak, K, Lycke, J, Frederiksen, JL, Drulovic, J, Confavreux, C, Brassat, D, Enzinger, C, Fuchs, S, Bosca, I, Pelletier, J, Picard, C, Colombo, E, Franciotta, D, Derfuss, T, Lindberg, RLP, Yaldizli, Ö, Vécsei, L, Kieseier, BC, Hartung, HP, Villoslada, P, Siva, A, Saiz, A, Tumani, H, Havrdová, E, Villar, LM, Leone, M, Barizzone, N, Deisenhammer, F, Teunissen, C, Montalban, X, Tintoré, M, Olsson, T, Trojano, M, Lehmann, S, Castelnovo, G, Lapin, S, Hintzen, R, Kappos, L, Furlan, R, Martinelli, V, Comi, G, Ramagopalan, SV, Giovannoni, G

Volltext

Month of birth as a risk factor for multiple sclerosis: an update von Torkildsen, O, Grytten, N, Aarseth, J, Myhr, K-M, Kampman, M T

Volltext

Response to ‘Seasonal variation of vitamin D and Epstein–Barr virus antibody in multiple sclerosis patients’, a comment letter regarding ‘Vitamin D, HLA ‐ DRB 1 and Epstein–Barr vi... von Wergeland, S., Riise, T., Torkildsen, Ø.

Volltext

Polyunsaturated fatty acids in multiple sclerosis therapy von Wergeland, S, Torkildsen, Ø, Bø, L, Myhr, K-M

Volltext

Vitamin D supplementation and monitoring in multiple sclerosis: who, when and wherefore von Holmøy, T, Torkildsen, Ø, Myhr, K-M, Løken-Amsrud, K I

Volltext

Fat-soluble vitamins as disease modulators in multiple sclerosis von Torkildsen, Ø, Løken-Amsrud, K I, Wergeland, S, Myhr, K-M, Holmøy, T

Volltext

The recurrence of disease activity after ocrelizumab discontinuation in multiple sclerosis von Coerver, E., Schoof, L., Hogenboom, L., Wessels, M., van Ruyven, P., van Samkar, A., Mostert, J., van Kempen, Z., van Oosten, B.W., Wokke, B.H., Tallantyre, E., Myhr, KM, Torkildsen, O., Killestein, J., Smets, I., Strijbis, E.

Volltext

A need for national registries and international collaborative research in multiple sclerosis von Myhr, K M, Grytten, N, Torkildsen, Ø, Wergeland, S, Bø, L, Pugliatti, M, Aarseth, J H

Volltext

Epstein-Barr virus reactivation and multiple sclerosis von Torkildsen, Ø., Nyland, H., Myrmel, H., Myhr, K.-M.

Volltext

Fcγ receptors in Norwegian multiple sclerosis patients and healthy controls von Gavasso, S, Torkildsen, Ø, Marøy, T H, Ulvestad, E, Myhr, K-M, Vedeler, C A

Volltext

Immunomodulatory treatment of multiple sclerosis in Norway von Torkildsen, Ø, Grytten, N, Myhr, K-M

Volltext

Selective and transient effect of vitamin D-3 supplementation on antibody responses against Epstein-Barr virus nuclear antigen 1 in relapsing-remitting multiple sclerosis von Rosjo, E., Lossius, A., Abdelmagid, N., Lindstrom, J. C., Kampman, M. T., Jorgensen, L., Sundström, Peter, Olsson, T., Steffensen, L. H., Torkildsen, O., Holmoy, T.

Volltext

International consensus on quality standards for brain health-focused care in multiple sclerosis von Hobart, Jeremy, Bowen, Amy, Pepper, George, Crofts, Harriet, Eberhard, Lucy, Berger, Thomas, Boyko, Alexey, Boz, Cavit, Butzkueven, Helmut, Celius, Elisabeth Gulowsen, Drulovic, Jelena, Flores, José, Horáková, Dana, Lebrun-Frénay, Christine, Marrie, Ruth Ann, Overell, James, Piehl, Fredrik, Rasmussen, Peter Vestergaard, Sá, Maria José, Sîrbu, Carmen-Adella, Skromne, Eli, Torkildsen, Øivind, van Pesch, Vincent, Vollmer, Timothy, Zakaria, Magd, Ziemssen, Tjalf, Giovannoni, Gavin

Volltext

Vitamin D, HLA ‐ DRB 1 and Epstein–Barr virus antibody levels in a prospective cohort of multiple sclerosis patients von Wergeland, S., Myhr, K.‐M., Løken‐Amsrud, K. I., Beiske, A. G., Bjerve, K. S., Hovdal, H., Midgard, R., Kvistad, S. S., Holmøy, T., Riise, T., Torkildsen, Ø.

Volltext

Effect of high-dose vitamin D3 supplementation on antibody responses against Epstein–Barr virus in relapsing-remitting multiple sclerosis von Røsjø, Egil, Lossius, Andreas, Abdelmagid, Nada, Lindstrøm, Jonas C, Kampman, Margitta T, Jørgensen, Lone, Sundström, Peter, Olsson, Tomas, Steffensen, Linn H, Torkildsen, Øivind, Holmøy, Trygve

Volltext